Aerpio Pharmaceuticals Commences Trading on the OTCQB® Market
CINCINNATI--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced today that shares of the Company’s common stock have been cleared for trading on the OTC Market Group's OTCQB® Market (“OTCQB”) in the United States. Shares of Aerpio’s common stock will trade under the ticker symbol "ARPO", effective at the market open on August 8, 2017. In March 2017, Aerpio raised approximately $40 m